BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
13 results:

  • 1. clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
    Nishii R; Saga T; Sudo H; Togawa T; Kuyama J; Tani T; Maeda T; Kobayashi M; Iizasa T; Shingyoji M; Itami M; Kawamura K; Hashimoto H; Yamazaki K; Tamura K; Higashi T
    Ann Nucl Med; 2021 Feb; 35(2):211-222. PubMed ID: 33387282
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
    Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
    J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With
    Palumbo B; Capozzi R; Bianconi F; Fravolini ML; Cascianelli S; Messina SG; Bellezza G; Sidoni A; Puma F; Ragusa M
    Anticancer Res; 2020 Jun; 40(6):3355-3360. PubMed ID: 32487631
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of pre-treatment
    Aktan M; Koc M; Kanyilmaz G; Yavuz BB
    Ann Nucl Med; 2017 Jul; 31(6):462-468. PubMed ID: 28516335
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
    Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
    Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging characteristics of stage I non-small cell lung cancer on CT and FDG-PET: relationship with epidermal growth factor receptor protein expression status and survival.
    Lee Y; Lee HJ; Kim YT; Kang CH; Goo JM; Park CM; Paeng JC; Chung DH; Jeon YK
    Korean J Radiol; 2013; 14(2):375-83. PubMed ID: 23483676
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. 3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
    Idema AJ; Hoffmann AL; Boogaarts HD; Troost EG; Wesseling P; Heerschap A; van der Graaf WT; Grotenhuis JA; Oyen WJ
    J Nucl Med; 2012 Dec; 53(12):1904-10. PubMed ID: 23077112
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
    Chang JY; Liu H; Balter P; Komaki R; Liao Z; Welsh J; Mehran RJ; Roth JA; Swisher SG
    Radiat Oncol; 2012 Sep; 7():152. PubMed ID: 22963661
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
    Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Surgical resection of pulmonary metastases from meningioma: report of a case.
    Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Tomita Y; Kodama K
    Surg Today; 2011 Jul; 41(7):995-8. PubMed ID: 21748620
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. clinical outcome in patients with intramedullary spinal cord metastases from lung cancer.
    Conill C; Marruecos J; Verger E; Berenguer J; Lomeña F; Domingo-Domènech J; Grau JJ; Casas F
    Clin Transl Oncol; 2007 Mar; 9(3):172-6. PubMed ID: 17403628
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Oligopeptides impairing the Myc-max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
    J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The influence of beam model differences in the comparison of dose calculation algorithms for lung cancer treatment planning.
    Chetty IJ; Rosu M; McShan DL; Fraass BA; Ten Haken RK
    Phys Med Biol; 2005 Mar; 50(5):801-15. PubMed ID: 15798256
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.